Adverum Biotechnologies
ADVM
ADVM
96 hedge funds and large institutions have $201M invested in Adverum Biotechnologies in 2018 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% more funds holding
Funds holding: 65 → 96 (+31)
1.3% more ownership
Funds ownership: 4.27% → 5.57% (+1.3%)
Holders
96
Holding in Top 10
–
Calls
$3.96M
Puts
$739K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$10.8M | |
| 3 | +$8.67M | |
| 4 |
Millennium Management
New York
|
+$8.28M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.7M |
Top Sellers
| 1 | -$2.8M | |
| 2 | -$2.6M | |
| 3 | -$2.23M | |
| 4 |
6CM
683 Capital Management
New York
|
-$1.93M |
| 5 |
Two Sigma Investments
New York
|
-$1.86M |